Baidu
map

全国政协委员研讨分级诊疗与多点执业:要给予中医药高度重视

2018-02-16 栗征 中国中医

人民政协报社邀请多名医药卫生界全国政协委员及相关专家,以“学习十九大精神·建设健康中国——落实分级诊疗与多点执业”为主题召开研讨会。多名委员提出,应注重发挥中医药在推动建立分级诊疗制度中的优势。

人民政协报社邀请多名医药卫生界全国政协委员及相关专家,以“学习十九大精神·建设健康中国——落实分级诊疗与多点执业”为主题召开研讨会。多名委员提出,应注重发挥中医药在推动建立分级诊疗制度中的优势。

“在分级诊疗中,要给予中医药高度重视。”十届全国政协委员、原卫生部副部长殷大奎表示,分级诊疗要把很多慢性病患者留在基层,中医药对此大有可为。“习近平总书记在全国卫生与健康大会上强调,要发挥中医药在治未病、重大疾病治疗、疾病康复中的重要作用。分级诊疗,尤其要发挥中医药在治未病中的主导作用和在疾病康复中的核心作用。”

研讨会现场。

全国政协委员、北京康益德中西医结合肺科医院董事长兼院长董瑞认为,中医医疗资源应率先下沉到基层。他表示,很多中医师具备全科医生的能力,能够“对症下药”弥补基层服务能力的不足,提高基层医务人员慢性病防治能力和水平。

十二届全国政协委员、北京顺天德中医医院院长王承德介绍,顺天德中医医院大部分专家来自中国中医科学院广安门医院,以前缺乏多点执业相关政策,许多医生不敢来。经多年呼吁,政府出台了多点执业政策,中医药法的颁布实施带来很多利好,使医生能横向纵向流动,为更多患者服务。但民营医疗机构整体生存环境仍然欠佳,许多政策没落地,希望国家对民营医疗机构给予各方面的政策支持。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2019-01-11 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-18 hb2008ye
  4. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-17 yfjms

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-17 驹迷一生

    中医是国宝.应该发扬光大

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-16 wzb521zf

    一起学习学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-16 邓启付

    国家越来越重视中医药的临床应用

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1822284, encodeId=08ed18222840c, content=<a href='/topic/show?id=c86d1023e19d' target=_blank style='color:#2F92EE;'>#高度重视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102371, encryptionId=c86d1023e19d, topicName=高度重视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Feb 27 18:24:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646272, encodeId=34f616462e2f5, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Fri Jan 11 06:24:00 CST 2019, time=2019-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409359, encodeId=2d64140935981, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627057, encodeId=ba8d162e057c1, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Sun Feb 18 06:24:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288587, encodeId=b6a828858eb4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Feb 17 08:06:45 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288558, encodeId=06782885586e, content=中医是国宝.应该发扬光大, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/20/325f09b1de43bf0f9a34e0f300559c38.jpg, createdBy=99df2253231, createdName=驹迷一生, createdTime=Sat Feb 17 06:56:28 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288435, encodeId=f5152884359c, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Feb 16 16:40:29 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288429, encodeId=3b662884294f, content=国家越来越重视中医药的临床应用, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzcjoLTEEgkSSQ8pVIiaf4a4INaoMLBV16QEk3dvvBRpicwIwmDGv0jePErJ4aE9ibVBDPtkialQLT9Bs/0, createdBy=04811949400, createdName=邓启付, createdTime=Fri Feb 16 16:38:27 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288427, encodeId=cab928842e69, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Feb 16 16:27:06 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-16 龙胆草

    学习谢谢分享

    0

Baidu
map
Baidu
map
Baidu
map